VijayBabuA

Wait for breakout

VijayBabuA 已更新   
NSE:STAR   STRIDES PHARMA SCI
path desider
评论:
it has crossed resistance with increased volumes following up day also has seen increased volume. initial target will be 396, 400 ( which is 200 DMA).

免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。